“cancer” Archives

in
Entry Author Date Location
A.I. Prizes, Coming to Healthcare, Hit $1M Mark in Cancer Contests 07/20/17 National
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Unanimous Advice To FDA: Approve Landmark CAR-T Cancer Therapy 07/12/17 National
Roundup: LiveOak, Memorial Hermann, AT&T, March Capital, & DigniCap 07/10/17 Texas
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal 07/06/17 New York
FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths 07/05/17 New York
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs 06/28/17 San Francisco
Startup Founder’s Quest for Cure Leads to Genomics Hackathon at Google 06/23/17 San Francisco
Repare Nabs $68M To Find Synthetic Lethal Cancer Targets Beyond PARP 06/22/17 Boston
New Ovarian Cancer Data Suggests Larger Role For Top Clovis Drug 06/19/17 Boulder/Denver
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
UT Health Cancer Center Hires Rare Blood Cancer Expert as Director 06/15/17 Texas
Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs 06/14/17 New York
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity 06/06/17 National
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters 06/02/17 Indiana
Mersana Plans IPO to Finance Clinical Trials for Breast Cancer Drug 06/02/17 Boston
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Array Lands $31M in Licensing Deal with Japan’s Ono Pharma 06/01/17 Boulder/Denver
Bicycle Therapeutics Maps Course to Clinic Backed by $52M Investment 06/01/17 Boston
Texas Cancer Agency Poised to Receive Two-Year Extension 05/31/17 Texas
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Constellation Reboots With Eye On Immuno-Oncology, Hires New CEO 05/25/17 Boston
Around Texas: Joseph Kopser, Mark Cuban, REVtech, Founder Institute 05/24/17 Texas
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Page 1 of 67 next page »